Prostate Cancer Prevention
Prostate cancer is by far the most common cancer in men and the second leading cause of death due to cancer. It comprises a mixed group of tumours displaying varying clinical behaviour: while some have a very aggressive course, others are rather indolent. Prevention of prostate cancer and discrimina...
Corporate Author: | |
---|---|
Other Authors: | , |
Format: | Electronic eBook |
Language: | English |
Published: |
Berlin, Heidelberg :
Springer Berlin Heidelberg : Imprint: Springer,
2014.
|
Series: | Recent Results in Cancer Research,
202 |
Subjects: | |
Online Access: | Full Text via HEAL-Link |
Table of Contents:
- Biology and natural history of prostate cancer
- Nutrition and prostate cancer
- Prostate cancer chemoprevention
- Lifestyle and dietary factors
- GWAS in prostate cancer predisposition and application to screening and prevention
- Risk prediction biomarkers – CCP
- Risk prediction biomarkers - TMPRSS2-ERG
- Risk prediction biomarkers – PCA3
- Risk adapted chemoprevention for PCa
- Outlook for 5α reductase inhibitors in prostate cancer prevention
- Prostate cancer chemoprevention: Aspirin
- Prostate cancer chemoprevention: DFMO
- Prostate cancer chemoprevention: Lycopene
- Distinguishing aggressive from indolent prostate cancer
- Prognosis and Management of low grade disease - Management of Gleason 6
- Prostate cancer prevention: Policy & Research implications.